Home
Conditions
Cytokine Release Syndrome

Clinical trial condition

Cytokine Release Syndrome

Explore clinical trials studying Cytokine Release Syndrome. Study availability and eligibility vary by location and protocol.

89 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Cytokine Release Syndrome trial results

Not Yet Recruiting

Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

NCT07497438

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +9 more
Locations: Intensive Care Unit - Avicenne Hospital, Assistance Publique des Hôpitaux de Paris Bobigny, France

View Trial Details

Not Yet Recruiting

Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries

NCT07393087

Conditions: Cardiac Surgery Recovery, Complex Cardiovascular Surgery With Cardiopulmonary Bypass, Cytokine Release Syndrome, +7 more
Locations: Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

View Trial Details

Not Yet Recruiting

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

NCT07166549

Conditions: B Cell Lymphoma, B Cell Malignancies, B-cell Leukemia, +25 more
Locations: University Hospital Basel, Division of Hematology or Medical Oncology Basel, Canton of Basel-City, Switzerland

View Trial Details

Not Yet Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients

NCT06308926

Conditions: Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Cytokine Storm, +11 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

NCT04150913

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

NCT04751643

Conditions: ARDS, Human, COVID-19, Coronaviridae Infections, +20 more
Locations: Centre Hospitalier William Morey Chalon-sur-Saône, France

Hôpital Edouard Herriot Lyon, France

Hôpital Croix Rousse Lyon, France

Clinique de la Sauvegarde Lyon, France

View Trial Details

Completed

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

NCT06279910

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +20 more
Locations: Complejo Hospitalario Universitario de Albacete Albacete, Spain

View Trial Details

Completed

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

NCT04979884

Conditions: COVID-19, COVID-19 Acute Respiratory Distress Syndrome, Coronaviridae Infections, +21 more
Locations: Alexandria university Alexandria, Egypt

View Trial Details

Completed

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

NCT04466098

Conditions: ARDS (Moderate or Severe), Acute Respiratory Distress Syndrome, COVID-19, +30 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Cytokine Release Syndrome

Cytokine Release Syndrome trial results

Related conditions